SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-004508
Filing Date
2013-01-07
Accepted
2013-01-07 08:10:57
Documents
3
Period of Report
2013-01-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d462566d8k.htm 8-K 17084
2 TRIUS THERAPEUTICS, INC. PRESS RELEASE d462566dex991.htm EX-99.1 9753
3 GRAPHIC g462566image001.jpg GRAPHIC 12025
  Complete submission text file 0001193125-13-004508.txt   44701
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34828 | Film No.: 13513789
SIC: 2834 Pharmaceutical Preparations